Info

JAMA Performance Improvement: Do No Harm

From the JAMA Network, this is JAMA Performance Improvement: Do No Harm, the podcast about performance improvement and medicine that aims to elevate the quality of care, one patient at a time, with host Ed Livingston, MD.
RSS Feed
JAMA Performance Improvement: Do No Harm
2020
December
November
April
January


2019
March
January


2018
March
February


2017
December
November
June
March
January


2016
December
September


All Episodes
Archives
Now displaying: Page 1
Nov 10, 2020

There are hundreds of thousands of liver transplant patients, all of whom will be seen in general clinical practices. It is common for them to develop elevated liver enzymes—a potentially serious problem that may be a sign that the transplanted liver is failing. Traditionally, patients with these findings are sent to a liver transplant center for an inpatient workup. A new protocol facilitating management of most of these patients in routine outpatient clinics has been developed, greatly improving the efficiency of managing patients with this clinical problem. Fady Kaldas, MD, director of the Dumont-UCLA transplant center, discusses how to manage elevated liver function results in liver transplant patients on an outpatient basis.

Related Article(s):

Outpatient Management of Liver Function Test Abnormalities in Patients With a Liver Transplant

0 Comments
Adding comments is not available at this time.